Jupiter Life Line Hospitals reports strong FY26 results led by operational efficiency
Jupiter Life Line Hospitals Limited reported a robust financial performance for FY26, with PAT rising 31% CAGR to ₹194.20 crore. EBITDA grew 17% CAGR to ₹343.30 crore, while revenue reached ₹1,499.78 crore. The newly operational Dombivli hospital and disciplined cost management were key drivers.

*this image is generated using AI for illustrative purposes only.
Jupiter Life Line Hospitals Limited has reported a robust financial performance for the financial year ended March 31, 2026, driven by operational efficiency and disciplined cost management. The company achieved a 15% CAGR in revenue from FY 2020-21 to FY 2025-26, reaching ₹1,499.78 crore.
Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) increased by 17% CAGR over the same period to ₹343.30 crore, with margins expanding to 22.89%. Profit After Tax (PAT) surged 31% CAGR to ₹194.20 crore, with margins at 12.95%.
Operationally, the hospital network maintained an average occupancy rate of 61.20% for FY 2025-26, which stood at 62.3% excluding the newly operational Dombivli hospital. The Average Revenue Per Occupied Bed (ARPOB) improved to ₹67,700, while the Average Length of Stay (ALOS) was 3.87 days.
Financial Performance
The company’s financial growth was underpinned by steady expansion and clinical capabilities. The Dombivli hospital, inaugurated on February 15, 2026, represents a significant addition to the network, strengthening the company’s foothold in the extended Mumbai Metropolitan Region. The project was delivered ahead of schedule, with construction and fit-outs completed in just over 25 months.
| Particulars | FY 2025-26 | |---| | Revenue from Operations (₹ in Crore) | 1,499.78 | | EBITDA (₹ in Crore) | 343.30 | | PAT (₹ in Crore) | 194.20 | | EBITDA Margins (%) | 22.89 | | PAT Margins (%) | 12.95 |
Operational Highlights
The operational metrics reflect efficient capacity utilisation and a growing patient base. The average occupancy rate was 61.20% for the full year. The ARPOB of ₹67,700 indicates an 11.70% increase from ₹60,600 in the previous year.
| Metric | Value |
|---|---|
| Average Occupancy Rate (%) | 61.20 |
| ARPOB (₹) | 67,700 |
| Average Length of Stay (Days) | 3.87 |
The company continues to focus on strengthening its clinical capabilities and expanding its network to reach emerging communities. With the Dombivli hospital now operational, the total operational bed capacity stands at 1,248. The company is also developing new facilities in South Pune, Mira Road, and BKC to further its reach.
Strategic Expansion
Jupiter Life Line Hospitals is executing a deliberate expansion strategy to build a ~3,000-bed integrated healthcare platform. The Dombivli hospital, with a planned capacity of 500 beds, is a key component of this strategy. The facility was developed with an investment of ₹425 crore and spans 7,50,000 sq. ft.
Future projects include a 300-bed hospital in Mira Road with an estimated investment of ₹400 crore and a ~400-bed hospital in BKC. These initiatives are designed to bring advanced multi-specialty healthcare closer to emerging communities.
Historical Stock Returns for Jupiter Life Line Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.57% | +0.17% | +8.92% | +10.35% | -3.65% | +35.33% |
How will the capital-intensive expansion into South Pune, Mira Road, and BKC impact the company's debt levels and leverage ratios in the near term?
What is the projected timeline for the Dombivli hospital to reach optimal occupancy levels, and how will its ramp-up phase affect overall margins in FY 2026-27?
Can the company sustain the current 11.7% growth in ARPOB amidst increasing competition in the Mumbai Metropolitan Region?































